4.5 Article

High-resolution quantitative proteome analysis reveals substantial differences between phagosomes of RAW 264.7 and bone marrow derived macrophages

期刊

PROTEOMICS
卷 15, 期 18, 页码 3169-3174

出版社

WILEY
DOI: 10.1002/pmic.201400431

关键词

Cell biology; Macrophage; Phagosome; Proteomics RAW 264.7

资金

  1. MRC PPU mass spec facility
  2. PRIDE team
  3. Wellcome Trust [097945/Z/11/Z]
  4. Medical Research Council UK
  5. AstraZeneca
  6. Boehringer-Ingelheim
  7. GlaxoSmithKline
  8. Janssen Pharmaceutica
  9. Merck KGaA
  10. Pfizer
  11. MRC [G1100713, MC_UP_A500_1020, MC_UU_12016/5] Funding Source: UKRI
  12. Medical Research Council [MC_UP_A500_1020, MC_UU_12016/5, G1100713] Funding Source: researchfish

向作者/读者索取更多资源

Macrophages are important immune cells operating at the forefront of innate immunity by taking up foreign particles and microbes through phagocytosis. The RAW 264.7 cell line is commonly used for experiments in the macrophage and phagocytosis field. However, little is known how its functions compare to primary macrophages. Here, we have performed an in-depth proteomics characterization of phagosomes from RAW 264.7 and bone marrow derived macrophages by quantifying more than 2500 phagosomal proteins. Our data indicate that there are significant differences for a large number of proteins including important receptors such as mannose receptor 1 and Siglec-1. Moreover, bone marrow derived macrophages phagosomes mature considerably faster by fusion with endosomes and the lysosome which we validated using fluorogenic phagocytic assays. We provide a valuable resource for researcher in the field and recommend careful use of the RAW 264.7 cell line when studying phagosome functions. All MS data have been deposited in the ProteomeXchange with identifier PXD001293 (http://proteomecentral.proteomexchange.org/dataset/PXD001293).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据